MX2021009293A - Indolo heptamyl oxime analogue as parp inhibitor. - Google Patents

Indolo heptamyl oxime analogue as parp inhibitor.

Info

Publication number
MX2021009293A
MX2021009293A MX2021009293A MX2021009293A MX2021009293A MX 2021009293 A MX2021009293 A MX 2021009293A MX 2021009293 A MX2021009293 A MX 2021009293A MX 2021009293 A MX2021009293 A MX 2021009293A MX 2021009293 A MX2021009293 A MX 2021009293A
Authority
MX
Mexico
Prior art keywords
heptamyl
indolo
parp inhibitor
oxime
analogue
Prior art date
Application number
MX2021009293A
Other languages
Spanish (es)
Inventor
Shuhui Chen
Gang Li
Yanbin Hu
Charles Z Ding
Fei Sun
Zhigang Chi
Jin Luo
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201910111577.2A external-priority patent/CN109848942A/en
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority claimed from PCT/CN2020/074220 external-priority patent/WO2020156577A1/en
Publication of MX2021009293A publication Critical patent/MX2021009293A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a type of indolo heptamyl oxime compounds as a PARP inhibitor. Specifically disclosed are a compound as represented by formula (II) and a pharmaceutically acceptable salt thereof.
MX2021009293A 2019-02-02 2020-02-03 Indolo heptamyl oxime analogue as parp inhibitor. MX2021009293A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201910107947 2019-02-02
CN201910111577.2A CN109848942A (en) 2019-02-12 2019-02-12 A kind of graphite electrode autoset road marking
CN201910684020 2019-07-26
PCT/CN2020/074220 WO2020156577A1 (en) 2019-02-02 2020-02-03 Indolo heptamyl oxime analogue as parp inhibitor

Publications (1)

Publication Number Publication Date
MX2021009293A true MX2021009293A (en) 2021-10-13

Family

ID=86499133

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009293A MX2021009293A (en) 2019-02-02 2020-02-03 Indolo heptamyl oxime analogue as parp inhibitor.

Country Status (1)

Country Link
MX (1) MX2021009293A (en)

Similar Documents

Publication Publication Date Title
MX2022011283A (en) Pyrimidoheterocyclic compounds and application thereof.
CR20220354A (en) Inhibitors of mutant forms of egfr
UY38057A (en) CARDIAC SARCOMER INHIBITORS
PH12020550034A1 (en) Aryl-phosphorus-oxygen compound as egfr kinase inhibitor
MX2023009278A (en) Pyrimidine aromatic ring compounds.
PH12021550400A1 (en) Cardiac sarcomere inhibitors
NZ779955A (en) Jak inhibitor compound and use thereof
MX2021007017A (en) 15-pgdh inhibitor.
MX2022000271A (en) Hpk1 inhibitors and uses thereof.
TN2011000400A1 (en) Inhibitors of beta-secretase
ZA202101487B (en) Novel compounds
MY193239A (en) Novel b-lactamase inhibitors
PH12016501846A1 (en) Tricyclic compound and jack inhibitor
MX2024005066A (en) Cd73 compounds.
MX2023001418A (en) Solid form of compound.
MY195576A (en) Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof
EA202092858A1 (en) PYRROLO [1,2-b] PYRIDAZINE DERIVATIVES
MX2021014629A (en) Tetracyclic compounds as cdc7 inhibitors.
MX2021009752A (en) 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative.
MX2021009293A (en) Indolo heptamyl oxime analogue as parp inhibitor.
MX2022004144A (en) Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers.
MX2021009261A (en) Fluorovinylbenzamide compound as pd-l1 immunomodulator.
JOP20220085A1 (en) Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
MX2023015440A (en) Sulfoximine compound and use thereof.
MX2023003280A (en) Fused tricyclic derivative and pharmaceutical application thereof.